Selected article for: "breath shortness and peripheral distribution"
Author: Ucpinar, Burcin Agridag; Sahin, Cennet; Yanc, Ugur
Title: Spontaneous Pneumothorax and Subcutaneous Emphysema in COVID-19 Patient: Case Report
  • Cord-id: uz0bdajz
  • Document date: 2020_5_26
    • ID: uz0bdajz
    Snippet: Coronavirus disease 2019 (COVÄ°D-19) is an infectious disease caused by severe acute respiratory syndrome virus coronavirus 2 (SARS-CoV-2).As known; COVID-19 has become a global pandemic and serious health problem. Disease mainly affects lungs and common findings are fever cough and shortness of breath. Computerized tomography(CT) has an important role in initial evaluation and follow up of COVID-19. Main (CT) finding of the disease is bilateral extensive ground-glass opacification (GGO) with a
    Document: Coronavirus disease 2019 (COVİD-19) is an infectious disease caused by severe acute respiratory syndrome virus coronavirus 2 (SARS-CoV-2).As known; COVID-19 has become a global pandemic and serious health problem. Disease mainly affects lungs and common findings are fever cough and shortness of breath. Computerized tomography(CT) has an important role in initial evaluation and follow up of COVID-19. Main (CT) finding of the disease is bilateral extensive ground-glass opacification (GGO) with a peripheral or posterior distribution, mainly involving the lower lobes. In this case report, we present a pneumothorax and subcutaneous emphysema case in a patient with COVID-19. To the best of authors’ knowledge; it is the first illustrated case of pneumothorax accompanying COVID-19 pneumonia.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and loss fatigue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • abdominal pain and lung affected organ: 1
    • abdominal pain and lung disease: 1, 2, 3, 4, 5, 6, 7
    • abdominal pain and lung involvement: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory syndrome virus and loss fatigue: 1, 2
    • acute respiratory syndrome virus and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome virus and lung involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • loss fatigue and lung disease: 1, 2
    • loss fatigue and lung involvement: 1
    • lung disease and lymphadenopathy cavitation: 1
    • lung involvement and lymphadenopathy cavitation: 1, 2